Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis
- PMID: 17090761
- DOI: 10.1001/jama.296.18.2201-a
Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis
Comment on
-
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.JAMA. 2006 May 17;295(19):2275-85. doi: 10.1001/jama.295.19.2275. JAMA. 2006. PMID: 16705109
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
